Severe Toxicity Following Synthetic Cannabinoid Ingestion

References

• EMCDDA. Understanding the ‘Spice’ phenomenon. European Monitoring Centre for Drugs and Drug Addiction EMCDDA 2009 Thematic paper ed: Office for Official Publications of the European Communities; 2009: 1–25.
   Google Scholar
• Dresen S, Ferreiros N, Putz M, Westphal F, Zimmermann R, Auwarter V. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J Mass Spectrom 2010; 45:1186–94.
   PubMed Web of Science ®Google Scholar
• Uchiyama N, Kikura-Hanajiri R, Kawahara N, Haishima Y, Goda Y. Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem Pharm Bull 2009; 57:439–441.
   PubMed Web of Science ®Google Scholar
• Hudson S, Ramsey J, King L, Timbers S, Maynard S, Dargan PL, Wood DM. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in “herbal high” products. J Anal Toxicol chem. 2010; 34:252–260.
   PubMed Web of Science ®Google Scholar
• Iversen LL. The Science of Marijuana Vol 2. 2nd. New York: Oxford University Press, Inc.; 2008.
   Google Scholar
• 21 Code of Federal Regulations: Part 1308, Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids Into Schedule I. 75, 2010: 71635–71638.
   Google Scholar
• Huffman JW. Cannabimimetic indoles, pyrroles, and indenes: structure-activity relationships and receptor interactions. Reggio PH. The Cannabinoid Receptors, The Receptors. 1: Humana Press; New York, NY 10013 2009: 49–94.
   Google Scholar
• Huffman JW, Padgett LW, Isherwood ML, Wiley JL, Martin BR. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorg Med Chem Lett 2006; 16:5432–5435.
   PubMed Web of Science ®Google Scholar
• Wiley JL, Compton DR, Dai D, Lainton JA, Phillips M, Huffman JW, Martin BR. Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J Pharmacol Exp Ther 1998; 285:995–1004.
   PubMed Web of Science ®Google Scholar
• Showalter VM, Compton DR, Martin BR, Abood ME. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 1996; 278: 89–999.
   Google Scholar
• Compton DR, Gold LH, Ward SJ, Balster RL, Martin BR. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J Pharmacol Exp Ther 1992; 263:1118–1126.
   PubMed Web of Science ®Google Scholar
• Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J Pharmacol Exp Ther 1992; 260: 201–209.
   PubMed Web of Science ®Google Scholar
• Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR, Martin BR. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 1993; 265:218–226.
   PubMed Web of Science ®Google Scholar
• Bell MR, D'Ambra TE, Kumar V, Eissenstat JL Jr, Wetzel JR, Rosi D, Phillon RE, Daum SJ, Hlasta DJ. Antinociceptive (aminoalkyl)indoles. J Med Chem 1991; 34:1099–1110.
   PubMed Web of Science ®Google Scholar
• Eissenstat MA, Bell MR, D'Ambra TE, Alexander EJ, Daum SJ, Ackerman JH, Gruett MD, Kumar V, Estep KG, Olefirwicz EM. Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics. J Med Chem 1995; 38:3094–3105.
   PubMed Web of Science ®Google Scholar
• Vearrier D, Osterhoudt KC. A teenager with agitation: higher than she should have climbed. Pediatr Emerg Care 2010; 26:462–465.
   PubMed Web of Science ®Google Scholar
• Muller H, Sperling W, Kohrmann M, Huttner HB, Kornhuber J, Maler JM. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res. 2010; 118:309–310.
   PubMed Web of Science ®Google Scholar
• Every-Palmer S. Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals. Addiction. 2010; 105:1859–1860.
   PubMed Web of Science ®Google Scholar
• Schneir AB, Cullen J, Ly BT. “Spice” Girls: Synthetic Cannabinoid Intoxication. J Emerg Med 2011; 40:296–9.
   PubMed Web of Science ®Google Scholar
• Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of “spice gold”. Dtsch Arztebl Int 2009; 106:464–467.
   PubMed Web of Science ®Google Scholar
• Gay M. Synthetic Marijuana Spurs State Bans. The New York Times July 10, 2010.
   Google Scholar
• Fisher WG. Inhaled incense “K2” may cause heart damage. Musings in the life of an internist, cardioloist and cardiac electrophysiologist. Vol 2010. August 15.ed. Evanston, IL, http://drwes.blogspot.com/2010/08/inhaled-incense-k2-may-cause-heart.html? 2010.
   Google Scholar
• Sobolevsky T, Prasolov I, Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci Int; 2010; 200:141–147.
   PubMed Web of Science ®Google Scholar
• Atwood BK, Mackie K. CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol 2010; 160:467–479.
   PubMed Web of Science ®Google Scholar
• Nyiri G, Cserep C, Szabadits E, Mackie K, Freund TF. CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience 2005; 136:811–822.
   PubMed Web of Science ®Google Scholar
• Tilelli JA, Spack LD. Marijuana intoxication presenting as seizure—comment. Pediatr Emerg Care 2006; 22:141.
   PubMed Web of Science ®Google Scholar
• Bonkowsky JL, Sarco D, Pomeroy SL. Ataxia and shaking in a 2-year-old girl: acute marijuana intoxication presenting as seizure. Pediatr Emerg Care 2005; 21:527–528.
   PubMed Web of Science ®Google Scholar
• Wallace MJ, Martin BR, DeLorenzo RJ. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 2002; 452:295–301.
   PubMed Web of Science ®Google Scholar
• Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol 2002; 42(11 Suppl):58S–63S.
   Google Scholar
• Kiplinger GF, Manno JE. Dose-response relationships to cannabis in human subjects. Pharmacol Rev 1971; 23:339–347.
   PubMed Web of Science ®Google Scholar
• Petronis KR, Anthony JC. An epidemiologic investigation of marijuana- and cocaine-related palpitations. Drug Alcohol Depend 1989; 23:219–226.
   PubMed Web of Science ®Google Scholar
• Aryana A, Williams MA. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty? Int J Cardiol 2007; 118:141–144.
   PubMed Web of Science ®Google Scholar
• Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction 1996; 91:1585–1614.
   PubMed Web of Science ®Google Scholar
• Chimalakonda KC, Bratton SM, Le VH, Yiew KH, Dineva A, Moran CL, . Conjugation of Synthetic Cannabinoids, JWH-018 [Naphthalen-1-yl-(1-pentylindol-3-yl)methanone] and JWH-073 [naphthalen-1-yl-(1-butylindol-3-yl)methanone], Metabolites by Human UDP-glucuronosyltransferases. Drug Metab Dispos 2011 Jul 11. [Epub ahead of print].
   Web of Science ®Google Scholar
• Moran CL, Le VH, Chimalakonda KC, Smedley AL, Lackey FD, Owen SN, . Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal Chem 2011; 1;83:4228–4236.
   Google Scholar
• Chimalakonda KC, Moran CL, Kennedy PD, Endres GW, Uzieblo A, Dobrowolski PJ, . Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine. Anal Chem 2011; 83:6381–8. [Epub 2010 Apr 28].
   PubMed Web of Science ®Google Scholar